Marharyta Semenikhina - Search Results

Year	Number of Results
2018	1
2019	1
2022	2
2023	6
2024	1

1

Nitric-Oxide-Mediated Signaling in Podocyte Pathophysiology.

Semenikhina M, Stefanenko M, Spires DR, Ilatovskaya DV, Palygin O. Semenikhina M, et al. Biomolecules. 2022 May 25;12(6):745. doi: 10.3390/biom12060745. Biomolecules. 2022. PMID: 35740870 Free PMC article. Review.

2

Protease-Activated Receptor 1-Mediated Damage of Podocytes in Diabetic Nephropathy.

Bohovyk R, Khedr S, Levchenko V, Stefanenko M, Semenikhina M, Kravtsova O, Isaeva E, Geurts AM, Klemens CA, Palygin O, Staruschenko A. Bohovyk R, et al. Among authors: semenikhina m. Diabetes. 2023 Dec 1;72(12):1795-1808. doi: 10.2337/db23-0032. Diabetes. 2023. PMID: 37722138

3

NNAT is a novel mediator of oxidative stress that suppresses ER + breast cancer.

Plasterer C, Semenikhina M, Tsaih SW, Flister MJ, Palygin O. Plasterer C, et al. Among authors: semenikhina m. Mol Med. 2023 Jul 3;29(1):87. doi: 10.1186/s10020-023-00673-y. Mol Med. 2023. PMID: 37400769 Free PMC article.

4

Endothelial mechanical stretch regulates the immunological synapse interface of renal endothelial cells in a sex-dependent manner.

Colvert CA, Hawkins KP, Semenikhina M, Stefanenko M, Pavlykivska O, Oates JC, DeLeon-Pennell KY, Palygin O, Van Beusecum JP. Colvert CA, et al. Among authors: semenikhina m. Am J Physiol Renal Physiol. 2023 Jul 1;325(1):F22-F37. doi: 10.1152/ajprenal.00258.2022. Epub 2023 May 11. Am J Physiol Renal Physiol. 2023. PMID: 37167273

5

β-Arrestin pathway activation by selective ATR1 agonism promotes calcium influx in podocytes, leading to glomerular damage.

Semenikhina M, Fedoriuk M, Stefanenko M, Klemens CA, Cherezova A, Marshall B, Hall G, Levchenko V, Solanki AK, Lipschutz JH, Ilatovskaya DV, Staruschenko A, Palygin O. Semenikhina M, et al. Clin Sci (Lond). 2023 Dec 22;137(24):1789-1804. doi: 10.1042/CS20230313. Clin Sci (Lond). 2023. PMID: 38051199

6

Breaking New Ground: The Crucial Role of Animal Research in the Advancement of Rhabdomyolysis-Induced AKI Treatment and Prevention.

Semenikhina M, Lipschutz JH, Palygin O. Semenikhina M, et al. Function (Oxf). 2023 Jul 26;4(5):zqad039. doi: 10.1093/function/zqad039. eCollection 2023. Function (Oxf). 2023. PMID: 37575481 Free PMC article. No abstract available.

7

Astrocytic responses to high glucose impair barrier formation in cerebral microvessel endothelial cells.

Garvin J, Semenikhina M, Liu Q, Rarick K, Isaeva E, Levchenko V, Staruschenko A, Palygin O, Harder D, Cohen S. Garvin J, et al. Among authors: semenikhina m. Am J Physiol Regul Integr Comp Physiol. 2022 Jun 1;322(6):R571-R580. doi: 10.1152/ajpregu.00315.2020. Epub 2022 Apr 12. Am J Physiol Regul Integr Comp Physiol. 2022. PMID: 35412389 Free PMC article.

8

Transcriptomic changes in glomeruli in response to a high salt challenge in the Dahl SS rat.

Semenikhina M, Lysikova DV, Spires DR, Domondon M, Stadler K, Palygin O, Ilatovskaya DV. Semenikhina M, et al. Physiol Genomics. 2024 Jan 1;56(1):98-111. doi: 10.1152/physiolgenomics.00075.2023. Epub 2023 Nov 13. Physiol Genomics. 2024. PMID: 37955135

9

Inhibition of protease-activated receptor 1 ameliorates behavioral deficits and restores hippocampal synaptic plasticity in a rat model of status epilepticus.

Semenikhina M, Bogovyk R, Fedoriuk M, Nikolaienko O, Al Kury LT, Savotchenko A, Krishtal O, Isaeva E. Semenikhina M, et al. Neurosci Lett. 2019 Jan 23;692:64-68. doi: 10.1016/j.neulet.2018.10.058. Epub 2018 Nov 1. Neurosci Lett. 2019. PMID: 30391321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year